This is the authors' abstract. We don't add key points for this paper.
Arylhydrazones represent a privileged class of scaffolds with diverse biological activities that are widely utilized in medicinal chemistry. Here, we report a mild yet effective strategy for constructing arylhydrazones via the in situ generation of DNA-conjugated aryl diazonium intermediates, followed by subsequent coupling with a variety of active methylene compounds. This method features broad substrate scopes, good to excellent conversions for both DNA-conjugated arylamine and DNA-conjugated active methylene coupling partners, and good compatibility with the DNA-encoded library (DEL) workflow, significantly expanding the accessible chemical space for DEL-based drug discovery.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: